1. Odvina CV, Zerwekh JE, Rao DS, et al. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 2005;90:1294-1301.
3. Allen MR, Burr DB. Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment. J Bone Miner Res 2007;22:1759-1765.
4. Lenart BA, Lorich DG, Lane JM. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 2008;358:1304-1306.
5. Koh JS, Goh SK, Png MA, et al. Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture? J Orthop Trauma 2010;24:75-81.
6. Shane E, Burr D, Ebeling PR, et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2010;25:2267-2294.
7. Unnanuntana A, Saleh A, Mensah KA, et al. Atypical femoral fractures: what do we know about them?: AAOS Exhibit Selection. J Bone Joint Surg Am 2013;95:e8 1-e8 13.
9. Rizzoli R, Akesson K, Bouxsein M, et al. Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. Osteoporos Int 2011;22:373-390.
11. Koh JS, Goh SK, Png MA, et al. Distribution of atypical fractures and cortical stress lesions in the femur: implications on pathophysiology. Singapore Med J 2011;52:77-80.
13. Schilcher J, Howe TS, Png MA, et al. Atypical fractures are mainly subtrochanteric in Singapore and diaphyseal in Sweden: A cross-sectional study. J Bone Miner Res 2015;30:2127-2132.
15. Marcano A, Taormina D, Egol KA, et al. Are race and sex associated with the occurrence of atypical femoral fractures? Clin Orthop Relat Res 2014;472:1020-1027.
16. Oh Y, Wakabayashi Y, Kurosa Y, et al. Potential pathogenic mechanism for stress fractures of the bowed femoral shaft in the elderly: Mechanical analysis by the CT-based finite element method. Injury 2014;45:1764-1771.
18. Kim JW, Kim JJ, Byun YS, et al. Factors affecting fracture location in atypical femoral fractures: a cross-sectional study with 147 patients. Injury 2017;48:1570-1574.
19. Oh Y, Fujita K, Wakabayashi Y, et al. Location of atypical femoral fracture can be determined by tensile stress distribution influenced by femoral bowing and neck-shaft angle: a CT-based nonlinear finite element analysis model for the assessment of femoral shaft loading stress. Injury 2017;48:2736-2743.
20. Chen LP, Chang TK, Huang TY, et al. The correlation between lateral bowing angle of the femur and the location of atypical femur fractures. Calcif Tissue Int 2014;95:240-247.
21. Soh HH, Chua IT, Kwek EB. Atypical fractures of the femur: effect of anterolateral bowing of the femur on fracture location. Arch Orthop Trauma Surg 2015;135:1485-1490.
22. Shane E, Burr D, Abrahamsen B, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2014;29:1-23.
23. Park YC, Song HK, Zheng XL, et al. Intramedullary nailing for atypical femoral fracture with excessive anterolateral bowing. J Bone Joint Surg Am 2017;99:726-735.
24. Martelli S, Pivonka P, Ebeling PR. Femoral shaft strains during daily activities: implications for atypical femoral fractures. Clin Biomech (Bristol, Avon) 2014;29:869-876.
27. Prasarn ML, Ahn J, Helfet DL, et al. Bisphosphonate-associated femur fractures have high complication rates with operative fixation. Clin Orthop Relat Res 2012;470:2295-2301.
28. van de Laarschot DM, Smits AA, Buitendijk SK, et al. Screening for atypical femur fractures using extended femur scans by DXA. J Bone Miner Res 2017;32:1632-1639.
29. McKenna MJ, McKiernan FE, McGowan B, et al. Identifying incomplete atypical femoral fractures with single-energy absorptiometry: Declining prevalence. J Endocr Soc 2017;1:211-220.